Evusheld drug approved for use in people aged 12 and older who are immunocompromised or for whom COVID-19 vaccination is not recommended.
Health Canada has authorized a drug developed by AstraZeneca to prevent COVID-19 infections.
Evusheld has been cleared for people aged 12 and older who have a compromised immune system and are unlikely to get an adequate response to a COVID-19 vaccination, or for whom COVID-19 vaccination is not recommended.
The medication contains lab-made antibodies designed to remain in the body for months, which officials say will contain the virus if there is an infection.
The therapy has also been authorized in the United States and has been recommended by the European Medicines Agency.
Province Investing Against Invasive Species
Niagara Driver Charged with Drug Impairment
Welland Man Arrested for Child Porn
28 More Doctors Hired in Niagara
Killed Police Officers Honoured by NRP
Niagara Wineries Shuttle Service Possible
Canal Days Vendors Warned of Scams
Niagara Falls Exploring Hub to Help Homeless